Merchants Bancorp (NASDAQ:MBIN) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.07 by 4.67 percent. This is a 1.75 percent decrease over earnings of $1.14 per share from the same period last year.
Revance Therapeutics Priced Upsized 8M Sharw Public Offering of Common Stock @$25/Share
Revance Therapeutics, Inc. (Nasdaq: RVNC) announced the pricing of an upsized underwritten public offering of 8,000,000 shares of its common stock. The shares of common stock are being offered at a public offering price of $25.00 per share. All of the shares are being offered by Revance.
